@Bunter62,
While some here are droning on negatively, I think they should ponder your words here #: 72890232 - what really got me excited last year during the MND trial was the announcement that they were observing the suppression of the inflammations associated with MND because research has pointed to MND inflammations as the likely source of the disease. (Of course the apparent stabilisation of the patients' health you point to needs more time before there can be an official announcement (recall that the intention is still for a slowing of MND's progress) but what a prospect !
Here's the summary of the original PharmAust ASX announcement:
4 July 2023
- Motor Neuron Disease Biomarkers and Pharmacodynamics Results• Preliminary data indicate suppression of inflammation that may be responsiblefor MND/ALS progression
https://announcements.asx.com.au/asxpdf/20230704/pdf/05r8yhtvvc5nb1.pdf
- Forums
- ASX - By Stock
- Ann: Positive clinical data filed with FDA to support ODD request
@Bunter62,While some here are droning on negatively, I think...
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.0¢ | $91.02K | 417.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2325 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 119713 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2325 | 0.215 |
7 | 63630 | 0.210 |
4 | 193228 | 0.205 |
9 | 159603 | 0.200 |
4 | 276128 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 119713 | 2 |
0.230 | 24215 | 3 |
0.235 | 50000 | 1 |
0.240 | 44200 | 1 |
0.245 | 55000 | 4 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
22.0¢ |
  |
Change
0.000 ( 5.72 %) |
|||
Open | High | Low | Volume | ||
23.0¢ | 23.0¢ | 21.0¢ | 271600 | ||
Last updated 15.42pm 06/05/2024 ? |
Featured News
PAA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online